On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...